SolveBio

SolveBio is a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises. The company works with diagnostic and R&D labs to massively scale their precision medicine offering. Screening, Rare Disease, and Oncology genetics requires accurate and fast assessment of variants. The SolveBio Genome Intelligence Service combines SolveBio’s proprietary data harmonization engine with a global network of trained genomics experts to deliver high-throughput, transparent, and reproducible DNA variant interpretation. SolveBio curation is scalable and available on-demand, allowing companies and labs to scale variant assessment as their test volume grows.
Company Growth (employees)
Type
Private
HQ
New York, US
Founded
2013
Size (employees)
13 (est)
SolveBio was founded in 2013 and is headquartered in New York, US

Key People at SolveBio

Mark Kaganovich

Mark Kaganovich

Founder
David Caplan

David Caplan

Co-Founder

SolveBio Office Locations

SolveBio has an office in New York
New York, US (HQ)
194 Mercer Street 627 Broadway

SolveBio Data and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$4 m

Time since last funding

almost 2 years

Investors

Traffic Overview of SolveBio

SolveBio Online and Social Media Presence

SolveBio News and Updates

Seven Bridges Announces Platform Integration with SolveBio

PRESS RELEASE: Seven Bridges, the biomedical data analysis company, and SolveBio today announced the integration of their complementary platforms for genomic data analysis. The integration of Seven Bridges' platform for cloud-based biomedical...

SolveBio Company Life and Culture

You may also be interested in